Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33799989)

  • 1. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine meat and milk factor protein expression in tumor-free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival.
    Nikitina E; Burk-Körner A; Wiesenfarth M; Alwers E; Heide D; Tessmer C; Ernst C; Krunic D; Schrotz-King P; Chang-Claude J; von Winterfeld M; Herpel E; Brobeil A; Brenner H; Heikenwalder M; Hoffmeister M; Kopp-Schneider A; Bund T
    Mol Oncol; 2024 May; 18(5):1076-1092. PubMed ID: 36811271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration.
    Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47.
    Huang C; Wang X; Wang Y; Feng Y; Wang X; Chen S; Yan P; Liao J; Zhang Q; Mao C; Li Y; Wang L; Wang X; Yi W; Cai W; Chen S; Hong N; He W; Chen J; Jin W
    Nat Cancer; 2024 Mar; 5(3):500-516. PubMed ID: 38200243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments.
    Benesova I; Capkova L; Ozaniak A; Pacas P; Kopeckova K; Galova D; Lischke R; Buchler T; Ozaniak Strizova Z
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):134. PubMed ID: 38493445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
    Vaccaro K; Allen J; Whitfield TW; Maoz A; Reeves S; Velarde J; Yang D; Meglan A; Ribeiro J; Blandin J; Phan N; Bell GW; Hata AN; Weiskopf K
    J Clin Invest; 2024 Mar; 134(9):. PubMed ID: 38483480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment.
    Inaguma S; Wang C; Ito S; Ueki A; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Takiguchi S; Schrump DS; Miettinen M; Takahashi S
    Pathobiology; 2024 Mar; ():1-13. PubMed ID: 38527431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors.
    Sosale NG; Ivanovska II; Tsai RK; Swift J; Hsu JW; Alvey CM; Zoltick PW; Discher DE
    Mol Ther Methods Clin Dev; 2016; 3():16080. PubMed ID: 28053997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer.
    Matsukawa T; Yoshikawa N; Liu W; Hattori S; Yoshida K; Yoshihara M; Tamauchi S; Yokoi A; Niimi K; Kajiyama H
    J Obstet Gynaecol Res; 2024 Apr; ():. PubMed ID: 38627199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer.
    Yang Y; Liu Q; Wang M; Li L; Yu Y; Pan M; Hu D; Chu B; Qu Y; Qian Z
    Signal Transduct Target Ther; 2024 Jun; 9(1):158. PubMed ID: 38862461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
    Vaccaro K; Allen J; Whitfield TW; Maoz A; Reeves S; Velarde J; Yang D; Phan N; Bell GW; Hata AN; Weiskopf K
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tumor-Associated Macrophages in Sarcomas.
    Fujiwara T; Healey J; Ogura K; Yoshida A; Kondo H; Hata T; Kure M; Tazawa H; Nakata E; Kunisada T; Fujiwara T; Ozaki T
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
    Lentz RW; Colton MD; Mitra SS; Messersmith WA
    Mol Cancer Ther; 2021 Jun; 20(6):961-974. PubMed ID: 33850005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.
    Yang Z; Peng Y; Guo W; Xu J; Li L; Tian H; Li R; Liu L; Tan F; Gao S; He J
    Thorac Cancer; 2021 Jun; 12(11):1743-1751. PubMed ID: 33979899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology and immunotherapy in gastric cancer.
    Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
    Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer.
    Feng C; Chen R; Fang W; Gao X; Ying H; Zheng X; Chen L; Jiang J
    Front Pharmacol; 2023; 14():1144330. PubMed ID: 37138855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy.
    Chen Y; Zhu Y; Kramer A; Fang Y; Wilson M; Li YR; Yang L
    Front Med (Lausanne); 2023; 10():1135468. PubMed ID: 37064017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.
    Sun TY; Nguyen B; Chen SB; Natkunam Y; Padda S; van de Rijn M; West R; Neal JW; Wakelee H; Riess JW
    JTO Clin Res Rep; 2023 Apr; 4(4):100498. PubMed ID: 37020927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
    Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
    Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.